Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 3, 2007, Pages 252-256

  Poulin, Céline ^a   Alary, Michel ^a,b,c   Lambert, Gilles ^c,d   Godin, Gaston ^a,b   Landry, Suzanne ^a   Gagnon, Hélène ^b   Demers, Éric ^a   Morarescu, Elena ^a   Rochefort, Jean ^c   Claessens, Christiane ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d Gouvernement du Quebec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEUTRON RADIATION; PREVALENCE; PRISON; RISK FACTOR; SALIVA; SEX DIFFERENCE; ADDICTION; ADULT; COMORBIDITY; CROSS-SECTIONAL STUDY; HIGH RISK BEHAVIOR; PREVENTIVE HEALTH SERVICE; SEX RATIO; SEXUAL BEHAVIOR; STATISTICS;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; PRISONS; QUEBEC; RISK FACTORS; RISK-TAKING; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS;

EID: 34547600573     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060760     Document Type: Article

References (31)

1. Stratégie québécoise de lutte contre l'infection par le VIH et le sida, l'infection par le VHC et les infections transmissibles sexuellement: orientations 2003-2009. Québec: Direction des communications, Ministère de la Santé et des Services sociaux; 2004. p. 56. Available: http://publications.msss.gouv.qc.ca/acrobat/f/ documentation /2003/03-320-01.pdf (accessed 2007 Mar 20).
2. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper. Geneva: World Health Organization, United Nations Office on Drugs and Crime, Joint United Nationals Programme on HIV/AIDS; 2004. Available: www.who.int/substance_abuse/ publications/en /PositionPaper_English.pdf (accessed 2007 Mar 20).
3. Kerr T, Jurgens R, Canadian HIV/AIDS Legal Network. Syringe exchange programs in prisons: reviewing the evidence. Toronto: Canadian HIV/AIDS Legal Network, 2004. Available: www.aidslaw.ca/publications/interfaces/ downloadFile.php?ref=166 (accessed 2007 Mar 20).
4. Hankins CA, Gendron S, Handley MA, et al. HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. Am J Public Health 1994;84:1637-40.
5. Dufour A, Alary M, Poulin C, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10:1009-15.
6. Gore SM, Bird AG, Burns SM, et al. Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ 1995;310:293-6.
7. Rotily M, Weilandt C, Bird SM, et al. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Eur J Public Health 2001;11:243-50.
8. Ford PM, Pearson M, Sankar-Mistry P, et al. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM 2000;93:113-9.
9. Allwright S, Bradley F, Long J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000;321:78-82.
10. Weild AR, Gill ON, Bennett D, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000;3:121-6.
11. De P, Connor N, Bouchard F, et al. HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention. Can J Infect Dis 2004;15:221-5.
12. Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005;41:177-86.
13. Ramuscak NL, Calzavara L, Burchell A, et al. HIV and hepatitis C (HCV) infection among Ontario inmates: Results from the Ontario remand study [abstract]. Can J Infect Dis 2005;16(Suppl A):33A.
14. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005;19(Suppl 3):S41-6.
15. Stark K, Bienzle U, Vonk R, et al. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997;26:1359-66.
16. Centers for Disease Control and Prevention (CDC). HIV transmission among male inmates in a state prison system - Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep 2006;55:421-6.
17. Calzavara LM, Burchell AN, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003;98:1257-65.
18. King A, Marion SA, Cook D, et al. Accuracy of a saliva test for HIV antibody. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:172-5.
19. Judd A, Parry J, Hickman M, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003;71:49-55.
20. Lowndes CM, Alary M. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study [letter]. Am J Epidemiol 1998;148:713-4.
21. Schechter MT, Strathdee SA, Cornelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS 1999;13:F45-51.
22. Alary M, Joly JR, Vincelette J, et al. Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men. Am J Public Health 2005;95:502-5.
23. Vandelli C, Renzo F, Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004;99:855-9.
24. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev 1996;18:137-48.
25. Hankins C, Gendron S, Handley M, et al. HIV-1 infection among incarcerated men - Quebec. Can Dis Wkly Rep 1991;17:233-5.
26. Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. CMAJ 1994;151:781-7.
27. Ford PM, White C, Kaufmann H, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995;153:1605-9.
28. Skoretz S. Zaniewski G, Goedhuis NJ. Hepatitis C virus transmission in the prison/inmate population. Can Commun Dis Rep 2004;30:141-8.
29. Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 2004;94:1218-23.
30. Long J, Allwright S, Barry J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ 2001;323:1209-13.
31. Babudieri S, Longo B, Sarmati L, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol 2005;76:311-7.